GLP-3 R Phase 2: −28.7%143 Compounds · 5 Layers>98% HPLC All VialsFree Shipping $200+Third-Party Test ReportsResearch Use OnlyCAS Numbers VerifiedGHK-Cu: 4,000+ GenesGLP-3 R Phase 2: −28.7%143 Compounds · 5 Layers>98% HPLC All VialsFree Shipping $200+Third-Party Test ReportsResearch Use OnlyCAS Numbers VerifiedGHK-Cu: 4,000+ Genes
Adipotide (FTPP) 10mg

Adipotide (FTPP) 10mg

Adipotide (FTPP)

CAS: 1180516-39-5

$134.99$149.9910% OFFIn Stock

Adipotide (FTPP) is a proapoptotic peptide that targets the vasculature of white adipose tissue via PROHIBITIN receptor binding on fat capillary endothelium. Phase 1 data in obese non-human primates showed significant visceral fat reduction with preservation of lean mass. 98.5% HPLC purity.

Specifications

Vial Size10mg
FormLyophilized Powder
Purity98.5% HPLC
CAS1180516-39-5
Storage-20C long-term
Shop This Compound

For laboratory research use only. Not for human consumption.

Mechanism of Action

Binds PROHIBITIN on adipose endothelial cells, triggering targeted apoptosis of fat vasculature. Unlike receptor agonists, adipotide works through a vascular pruning mechanism — reducing blood supply to fat depots selectively.

Research FAQ

How does Adipotide differ from GLP agonists?

GLP agonists reduce caloric intake and improve insulin sensitivity. Adipotide directly targets fat tissue vasculature for apoptosis — a completely different mechanism with no receptor agonism or hormonal effects.

Related Compounds